NEWARK, Del. & SEATTLE--(BUSINESS WIRE)--SDI (Strategic Diagnostics Inc., Nasdaq: SDIX), a provider of biotechnology-based products and services, and Fred Hutchinson Cancer Research Center (the Hutchinson Center) today jointly announced they will collaborate to discover biomarkers for use in the early detection of a variety of cancers. Initial studies will center on pancreatic cancer.
